The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Transmucosal Drugs Market Research Report 2024
Synopsis
Oral Transmucosal Drugs
The global Oral Transmucosal Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Transmucosal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Transmucosal Drugs.
Report Scope
The Oral Transmucosal Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Transmucosal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Transmucosal Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company
Segment by Type
Tablets
Films
Liquid Spray
Gels
Others
Segment by Application
Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Transmucosal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Transmucosal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Oral Transmucosal Drugs
The global Oral Transmucosal Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Transmucosal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Transmucosal Drugs.
Report Scope
The Oral Transmucosal Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Transmucosal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Transmucosal Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company
Segment by Type
Tablets
Films
Liquid Spray
Gels
Others
Segment by Application
Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Transmucosal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Transmucosal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Transmucosal Drugs Market Overview
1.1 Product Overview and Scope of Oral Transmucosal Drugs
1.2 Oral Transmucosal Drugs Segment by Type
1.2.1 Global Oral Transmucosal Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Films
1.2.4 Liquid Spray
1.2.5 Gels
1.2.6 Others
1.3 Oral Transmucosal Drugs Segment by Application
1.3.1 Global Oral Transmucosal Drugs Market Value by Application: (2024-2030)
1.3.2 Cardiovascular Disorders
1.3.3 Acute Pain Managements
1.3.4 Diabetes
1.3.5 Others
1.4 Global Oral Transmucosal Drugs Market Size Estimates and Forecasts
1.4.1 Global Oral Transmucosal Drugs Revenue 2019-2030
1.4.2 Global Oral Transmucosal Drugs Sales 2019-2030
1.4.3 Global Oral Transmucosal Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Transmucosal Drugs Market Competition by Manufacturers
2.1 Global Oral Transmucosal Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Transmucosal Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Transmucosal Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Oral Transmucosal Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Transmucosal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Transmucosal Drugs, Product Type & Application
2.7 Oral Transmucosal Drugs Market Competitive Situation and Trends
2.7.1 Oral Transmucosal Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Transmucosal Drugs Players Market Share by Revenue
2.7.3 Global Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Transmucosal Drugs Retrospective Market Scenario by Region
3.1 Global Oral Transmucosal Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Transmucosal Drugs Global Oral Transmucosal Drugs Sales by Region: 2019-2030
3.2.1 Global Oral Transmucosal Drugs Sales by Region: 2019-2024
3.2.2 Global Oral Transmucosal Drugs Sales by Region: 2025-2030
3.3 Global Oral Transmucosal Drugs Global Oral Transmucosal Drugs Revenue by Region: 2019-2030
3.3.1 Global Oral Transmucosal Drugs Revenue by Region: 2019-2024
3.3.2 Global Oral Transmucosal Drugs Revenue by Region: 2025-2030
3.4 North America Oral Transmucosal Drugs Market Facts & Figures by Country
3.4.1 North America Oral Transmucosal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Transmucosal Drugs Sales by Country (2019-2030)
3.4.3 North America Oral Transmucosal Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Transmucosal Drugs Market Facts & Figures by Country
3.5.1 Europe Oral Transmucosal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Transmucosal Drugs Sales by Country (2019-2030)
3.5.3 Europe Oral Transmucosal Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Transmucosal Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Transmucosal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Transmucosal Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Transmucosal Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oral Transmucosal Drugs Market Facts & Figures by Country
3.7.1 Latin America Oral Transmucosal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Transmucosal Drugs Sales by Country (2019-2030)
3.7.3 Latin America Oral Transmucosal Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Transmucosal Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Transmucosal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Transmucosal Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Transmucosal Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Transmucosal Drugs Sales by Type (2019-2030)
4.1.1 Global Oral Transmucosal Drugs Sales by Type (2019-2024)
4.1.2 Global Oral Transmucosal Drugs Sales by Type (2025-2030)
4.1.3 Global Oral Transmucosal Drugs Sales Market Share by Type (2019-2030)
4.2 Global Oral Transmucosal Drugs Revenue by Type (2019-2030)
4.2.1 Global Oral Transmucosal Drugs Revenue by Type (2019-2024)
4.2.2 Global Oral Transmucosal Drugs Revenue by Type (2025-2030)
4.2.3 Global Oral Transmucosal Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Oral Transmucosal Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Transmucosal Drugs Sales by Application (2019-2030)
5.1.1 Global Oral Transmucosal Drugs Sales by Application (2019-2024)
5.1.2 Global Oral Transmucosal Drugs Sales by Application (2025-2030)
5.1.3 Global Oral Transmucosal Drugs Sales Market Share by Application (2019-2030)
5.2 Global Oral Transmucosal Drugs Revenue by Application (2019-2030)
5.2.1 Global Oral Transmucosal Drugs Revenue by Application (2019-2024)
5.2.2 Global Oral Transmucosal Drugs Revenue by Application (2025-2030)
5.2.3 Global Oral Transmucosal Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Oral Transmucosal Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 LTS Lohmann Therapie-Systeme AG
6.1.1 LTS Lohmann Therapie-Systeme AG Corporation Information
6.1.2 LTS Lohmann Therapie-Systeme AG Description and Business Overview
6.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Portfolio
6.1.5 LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
6.2 Soligenix
6.2.1 Soligenix Corporation Information
6.2.2 Soligenix Description and Business Overview
6.2.3 Soligenix Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Soligenix Oral Transmucosal Drugs Product Portfolio
6.2.5 Soligenix Recent Developments/Updates
6.3 ZIM Laboratories Limited
6.3.1 ZIM Laboratories Limited Corporation Information
6.3.2 ZIM Laboratories Limited Description and Business Overview
6.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs Product Portfolio
6.3.5 ZIM Laboratories Limited Recent Developments/Updates
6.4 Access Pharmaceutical Inc.
6.4.1 Access Pharmaceutical Inc. Corporation Information
6.4.2 Access Pharmaceutical Inc. Description and Business Overview
6.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Portfolio
6.4.5 Access Pharmaceutical Inc. Recent Developments/Updates
6.5 C.L Pharm
6.5.1 C.L Pharm Corporation Information
6.5.2 C.L Pharm Description and Business Overview
6.5.3 C.L Pharm Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 C.L Pharm Oral Transmucosal Drugs Product Portfolio
6.5.5 C.L Pharm Recent Developments/Updates
6.6 Cure Pharmaceutical
6.6.1 Cure Pharmaceutical Corporation Information
6.6.2 Cure Pharmaceutical Description and Business Overview
6.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cure Pharmaceutical Oral Transmucosal Drugs Product Portfolio
6.6.5 Cure Pharmaceutical Recent Developments/Updates
6.7 Aquestive Therapeutics, Inc.
6.6.1 Aquestive Therapeutics, Inc. Corporation Information
6.6.2 Aquestive Therapeutics, Inc. Description and Business Overview
6.6.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Portfolio
6.7.5 Aquestive Therapeutics, Inc. Recent Developments/Updates
6.8 NAL Pharma
6.8.1 NAL Pharma Corporation Information
6.8.2 NAL Pharma Description and Business Overview
6.8.3 NAL Pharma Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 NAL Pharma Oral Transmucosal Drugs Product Portfolio
6.8.5 NAL Pharma Recent Developments/Updates
6.9 IntelGenx Corp.
6.9.1 IntelGenx Corp. Corporation Information
6.9.2 IntelGenx Corp. Description and Business Overview
6.9.3 IntelGenx Corp. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 IntelGenx Corp. Oral Transmucosal Drugs Product Portfolio
6.9.5 IntelGenx Corp. Recent Developments/Updates
6.10 Eisai Co., Ltd.
6.10.1 Eisai Co., Ltd. Corporation Information
6.10.2 Eisai Co., Ltd. Description and Business Overview
6.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Eisai Co., Ltd. Oral Transmucosal Drugs Product Portfolio
6.10.5 Eisai Co., Ltd. Recent Developments/Updates
6.11 Otsuka Pharmaceutical Co., Ltd.
6.11.1 Otsuka Pharmaceutical Co., Ltd. Corporation Information
6.11.2 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Description and Business Overview
6.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Portfolio
6.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Teva Pharmaceutical Industries Ltd.
6.12.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.12.2 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Description and Business Overview
6.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Portfolio
6.12.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.13 GlaxoSmithKline plc
6.13.1 GlaxoSmithKline plc Corporation Information
6.13.2 GlaxoSmithKline plc Oral Transmucosal Drugs Description and Business Overview
6.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 GlaxoSmithKline plc Oral Transmucosal Drugs Product Portfolio
6.13.5 GlaxoSmithKline plc Recent Developments/Updates
6.14 Viatris
6.14.1 Viatris Corporation Information
6.14.2 Viatris Oral Transmucosal Drugs Description and Business Overview
6.14.3 Viatris Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Viatris Oral Transmucosal Drugs Product Portfolio
6.14.5 Viatris Recent Developments/Updates
6.15 Bristol-Myers Squibb Company
6.15.1 Bristol-Myers Squibb Company Corporation Information
6.15.2 Bristol-Myers Squibb Company Oral Transmucosal Drugs Description and Business Overview
6.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Portfolio
6.15.5 Bristol-Myers Squibb Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Transmucosal Drugs Industry Chain Analysis
7.2 Oral Transmucosal Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Transmucosal Drugs Production Mode & Process
7.4 Oral Transmucosal Drugs Sales and Marketing
7.4.1 Oral Transmucosal Drugs Sales Channels
7.4.2 Oral Transmucosal Drugs Distributors
7.5 Oral Transmucosal Drugs Customers
8 Oral Transmucosal Drugs Market Dynamics
8.1 Oral Transmucosal Drugs Industry Trends
8.2 Oral Transmucosal Drugs Market Drivers
8.3 Oral Transmucosal Drugs Market Challenges
8.4 Oral Transmucosal Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oral Transmucosal Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Transmucosal Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Transmucosal Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Transmucosal Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Transmucosal Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Transmucosal Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Transmucosal Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Transmucosal Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Transmucosal Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Transmucosal Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Transmucosal Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Oral Transmucosal Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Transmucosal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Transmucosal Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Transmucosal Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Transmucosal Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral Transmucosal Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Oral Transmucosal Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral Transmucosal Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Oral Transmucosal Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Transmucosal Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Transmucosal Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Transmucosal Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Transmucosal Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Transmucosal Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral Transmucosal Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral Transmucosal Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Transmucosal Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Transmucosal Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Transmucosal Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral Transmucosal Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral Transmucosal Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Transmucosal Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Transmucosal Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Transmucosal Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral Transmucosal Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral Transmucosal Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Transmucosal Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Transmucosal Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Transmucosal Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral Transmucosal Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral Transmucosal Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Transmucosal Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Transmucosal Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Transmucosal Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Oral Transmucosal Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Transmucosal Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Oral Transmucosal Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Oral Transmucosal Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Oral Transmucosal Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Oral Transmucosal Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Transmucosal Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Transmucosal Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Transmucosal Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Transmucosal Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Oral Transmucosal Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Oral Transmucosal Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Oral Transmucosal Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Oral Transmucosal Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Oral Transmucosal Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Oral Transmucosal Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Transmucosal Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Transmucosal Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Transmucosal Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Transmucosal Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Oral Transmucosal Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. LTS Lohmann Therapie-Systeme AG Corporation Information
Table 71. LTS Lohmann Therapie-Systeme AG Description and Business Overview
Table 72. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product
Table 74. LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
Table 75. Soligenix Corporation Information
Table 76. Soligenix Description and Business Overview
Table 77. Soligenix Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Soligenix Oral Transmucosal Drugs Product
Table 79. Soligenix Recent Developments/Updates
Table 80. ZIM Laboratories Limited Corporation Information
Table 81. ZIM Laboratories Limited Description and Business Overview
Table 82. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. ZIM Laboratories Limited Oral Transmucosal Drugs Product
Table 84. ZIM Laboratories Limited Recent Developments/Updates
Table 85. Access Pharmaceutical Inc. Corporation Information
Table 86. Access Pharmaceutical Inc. Description and Business Overview
Table 87. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product
Table 89. Access Pharmaceutical Inc. Recent Developments/Updates
Table 90. C.L Pharm Corporation Information
Table 91. C.L Pharm Description and Business Overview
Table 92. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. C.L Pharm Oral Transmucosal Drugs Product
Table 94. C.L Pharm Recent Developments/Updates
Table 95. Cure Pharmaceutical Corporation Information
Table 96. Cure Pharmaceutical Description and Business Overview
Table 97. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Cure Pharmaceutical Oral Transmucosal Drugs Product
Table 99. Cure Pharmaceutical Recent Developments/Updates
Table 100. Aquestive Therapeutics, Inc. Corporation Information
Table 101. Aquestive Therapeutics, Inc. Description and Business Overview
Table 102. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product
Table 104. Aquestive Therapeutics, Inc. Recent Developments/Updates
Table 105. NAL Pharma Corporation Information
Table 106. NAL Pharma Description and Business Overview
Table 107. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. NAL Pharma Oral Transmucosal Drugs Product
Table 109. NAL Pharma Recent Developments/Updates
Table 110. IntelGenx Corp. Corporation Information
Table 111. IntelGenx Corp. Description and Business Overview
Table 112. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. IntelGenx Corp. Oral Transmucosal Drugs Product
Table 114. IntelGenx Corp. Recent Developments/Updates
Table 115. Eisai Co., Ltd. Corporation Information
Table 116. Eisai Co., Ltd. Description and Business Overview
Table 117. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Eisai Co., Ltd. Oral Transmucosal Drugs Product
Table 119. Eisai Co., Ltd. Recent Developments/Updates
Table 120. Otsuka Pharmaceutical Co., Ltd. Corporation Information
Table 121. Otsuka Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product
Table 124. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 126. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 127. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product
Table 129. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 130. GlaxoSmithKline plc Corporation Information
Table 131. GlaxoSmithKline plc Description and Business Overview
Table 132. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. GlaxoSmithKline plc Oral Transmucosal Drugs Product
Table 134. GlaxoSmithKline plc Recent Developments/Updates
Table 135. Viatris Corporation Information
Table 136. Viatris Description and Business Overview
Table 137. Viatris Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Viatris Oral Transmucosal Drugs Product
Table 139. Viatris Recent Developments/Updates
Table 140. Bristol-Myers Squibb Company Corporation Information
Table 141. Bristol-Myers Squibb Company Description and Business Overview
Table 142. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product
Table 144. Bristol-Myers Squibb Company Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Oral Transmucosal Drugs Distributors List
Table 148. Oral Transmucosal Drugs Customers List
Table 149. Oral Transmucosal Drugs Market Trends
Table 150. Oral Transmucosal Drugs Market Drivers
Table 151. Oral Transmucosal Drugs Market Challenges
Table 152. Oral Transmucosal Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Transmucosal Drugs
Figure 2. Global Oral Transmucosal Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Transmucosal Drugs Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Films Product Picture
Figure 6. Liquid Spray Product Picture
Figure 7. Gels Product Picture
Figure 8. Others Product Picture
Figure 9. Global Oral Transmucosal Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Oral Transmucosal Drugs Market Share by Application in 2023 & 2030
Figure 11. Cardiovascular Disorders
Figure 12. Acute Pain Managements
Figure 13. Diabetes
Figure 14. Others
Figure 15. Global Oral Transmucosal Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Oral Transmucosal Drugs Market Size (2019-2030) & (US$ Million)
Figure 17. Global Oral Transmucosal Drugs Sales (2019-2030) & (K Units)
Figure 18. Global Oral Transmucosal Drugs Average Price (US$/Unit) & (2019-2030)
Figure 19. Oral Transmucosal Drugs Report Years Considered
Figure 20. Oral Transmucosal Drugs Sales Share by Manufacturers in 2023
Figure 21. Global Oral Transmucosal Drugs Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Oral Transmucosal Drugs Players: Market Share by Revenue in 2023
Figure 23. Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Oral Transmucosal Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Oral Transmucosal Drugs Sales Market Share by Country (2019-2030)
Figure 26. North America Oral Transmucosal Drugs Revenue Market Share by Country (2019-2030)
Figure 27. United States Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Oral Transmucosal Drugs Sales Market Share by Country (2019-2030)
Figure 30. Europe Oral Transmucosal Drugs Revenue Market Share by Country (2019-2030)
Figure 31. Germany Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Oral Transmucosal Drugs Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Oral Transmucosal Drugs Revenue Market Share by Region (2019-2030)
Figure 38. China Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Oral Transmucosal Drugs Sales Market Share by Country (2019-2030)
Figure 48. Latin America Oral Transmucosal Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Oral Transmucosal Drugs Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Oral Transmucosal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Oral Transmucosal Drugs by Type (2019-2030)
Figure 58. Global Revenue Market Share of Oral Transmucosal Drugs by Type (2019-2030)
Figure 59. Global Oral Transmucosal Drugs Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Oral Transmucosal Drugs by Application (2019-2030)
Figure 61. Global Revenue Market Share of Oral Transmucosal Drugs by Application (2019-2030)
Figure 62. Global Oral Transmucosal Drugs Price (US$/Unit) by Application (2019-2030)
Figure 63. Oral Transmucosal Drugs Value Chain
Figure 64. Oral Transmucosal Drugs Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
